Fortis Capital Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Sell
3,873
-639
-14% -$51.5K 0.03% 327
2026
Q1
$391K Sell
4,512
-155
-3% -$14.8K 0.05% 265
2025
Q4
$448K Buy
4,667
+2,469
+112% +$240K 0.07% 206
2025
Q3
$209K Buy
+2,198
New +$202K 0.03% 264
2024
Q2
Sell
-4,981
Closed -$434K 180
2024
Q1
$434K Buy
4,981
+716
+17% +$61.1K 0.18% 101
2023
Q4
$351K Hold
4,265
0.19% 77
2023
Q3
$334K Buy
4,265
+610
+17% +$51.1K 0.21% 69
2023
Q2
$322K Hold
3,655
0.19% 76
2023
Q1
$295K Hold
3,655
0.16% 86
2022
Q4
$284K Buy
+3,655
New +$296K 0.17% 83

Other funds holding MDT

Fortis Capital Advisors's MDT Position: Q2 2026 in Review

Fortis Capital Advisors reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $51.5K and leaving 3,873 shares worth $303K. The position accounts for 0.03% of the portfolio, ranked #327.

Fortis Capital Advisors first reported a position in MDT in Q4 2022 and has held it in 10 quarters since. The position peaked at $448K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fortis Capital Advisors held 3,873 shares of Medtronic worth $303K as of Q2 2026.
  • Fortis Capital Advisors sold 639 Medtronic shares in Q2 2026, an estimated $51.5K.
  • Medtronic made up 0.03% of Fortis Capital Advisors's portfolio in Q2 2026, its #327 holding.
  • Fortis Capital Advisors first reported a position in Medtronic in Q4 2022 and has held it in 10 quarters since.
  • Fortis Capital Advisors's Medtronic position peaked at $448K in Q4 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.